Research Article
Quantitative Analysis of Favipiravir by HPLC: Development and Validation
| Sa. # | Area of standard | % assay | Area of sample | % |
| Analyst 1 | 1 | 36.877 | 36.941 | 100.1% | 2 | 36.967 | 36.133 | 97.9% | 3 | 36.958 | 36.779 | 99.7% | 4 | 36.884 | 36.963 | 100.2% | 5 | 36.952 | 36.999 | 100.3% | 6 | 36.788 | 37.009 | 100.3% | Avg | 36.9 | 36.804 | 99.7% | RSD | 0.2% | 0.9% | 0.9% |
| Analyst 2 | 1 | 36.407 | 36.679 | 98.6% | 2 | 36.491 | 36.292 | 97.6% | 3 | 36.390 | 37.384 | 100.5% | 4 | 36.512 | 35.963 | 96.7% | 5 | 36.432 | 36.680 | 98.6% | 6 | 36.479 | 35.743 | 96.1% | Avg | 36.5 | 36.457 | 98.0% | RSD | 0.1% | 1.6% | 1.6% |
| | Absolute difference | — | — | 1.5% | RSD (all) | | | For both analysts |
|
|